Choose expression modality
Compare molecular architectures and stage-appropriate verification plans. For non-amplifying, protein-coding mRNA sequence hypotheses, use the DBTL & Structure Intelligence Workbench ↗ or the Coding + 5′/3′ UTR Design Workbench ↗.
Optional reference length; not a computed final RNA length.
For protein-coding RNA only; separate SeqFold tool.
saRNA is ambiguous: small activating RNA (RNAa) and self-amplifying RNA are separate modalities. No guide RNA, replicase, CAR, or clinical construct sequences are generated here.
Conceptual architecture
Diagram shows functional modules; not proportional, sequence-validated, or an assembly protocol.
Independent validation priorities
Biological design interpretation
Review flags
Downstream tools and evidence
Use the complementary studios after establishing a defensible construct design and assay plan.
CDS + 5′/3′ UTR Design Workbench ↗New v1.7: DBTL & Structure Intelligence ↗Back-translation / codon studio ↗Cloning workbench ↗LNP feasibility ↗RNA / LNP analytical QC ↗Assay interpretation ↗Review: conventional and self-amplifying mRNA ↗
Research-only architecture options require sequence-specific QC, applicable IP/FTO review, safety and performance testing in an appropriate regulated setting. No claims of expression, efficacy, or manufacturability are made.